跳至主要内容
临床试验/NCT04123145
NCT04123145Unknown不适用

Study of the Prevalence of Iron Deficiency in Patients With Chronic Renal Failure But Non-Dialysis (CARENFER IRC-ND)

VIFORFRANCE0 个研究点目标入组 1,100 人开始时间: 2019年10月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
1,100
主要终点
Complete blood iron status

研究概览

简要总结

Despite its known prevalence, a recent study conducted with Prof. Cacoub (unpublished) on the national health insurance database showed that iron deficiency was a poorly diagnosed and poorly treated comorbidity. In patients with Chronic Kidney Disease but Non-Dialysis, the determination of Ferritinemia and Transferrin Saturation Factoris performed in only 30% and 10% of cases whereas they should be performed routinely in inflammatory situations and in case of anemia (HAS 2011, KDIGO 2012). The objective of this study is to obtain updated data on the prevalence of iron deficiency in France in patients with CKD-ND, applying the international recommendations and those of the French Health High Authority (determination of ferritinemia and Transferrin Saturation Factor).

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient, male or female, over 18 years of age;
  • Patient present at the hospital on the day of the study (traditional hospitalization, week hospital, day hospital, or in consultation with CKD-ND);
  • Diagnosis of CKD-ND (glomerular filtration rate (GFR) > 15 mL/min/1.73 m²)
  • Patient with signed consent

排除标准

  • Protected patient: major under guardianship, tutorship or other legal protection, deprived of liberty by judicial or administrative decision;
  • Pregnant or breastfeeding woman;
  • Patient with dialysis

研究组 & 干预措施

CDK-ND

Experimental

干预措施: Iron status testing (Diagnostic Test)

结局指标

主要结局

Complete blood iron status

时间窗: One day

ferritin

次要结局

未报告次要终点

研究者

发起方
VIFORFRANCE
申办方类型
Industry
责任方
Sponsor

相似试验